Improving diagnostic efficacy of primary prostate cancer with combined 99mTc-PSMA SPECT/CT and multiparametric-MRI and quantitative parameters
PurposeThis prospective study aimed to evaluate the difference between 99mTc-PSMA single-photon emission computed tomography (SPECT)/CT and multiparametric magnetic resonance imaging (mpMRI) in the detection of primary prostate cancer (PCa).Materials and methodsFifty-six men with suspected PCa betwe...
Main Authors: | Yu Zhang, Yuanying Shi, Liefu Ye, Tao Li, Yongbao Wei, Zhiyi Lin, Wenxin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1193370/full |
Similar Items
-
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
by: Yu Zhang, et al.
Published: (2022-09-01) -
Synthesis and preclinical evaluation of novel 99mTc-labeled PSMA ligands for radioguided surgery of prostate cancer
by: Jan-Philip Kunert, et al.
Published: (2023-01-01) -
Radiochemical and biological assessments of a PSMA-I&S cold kit for fast and inexpensive 99mTc-labeling for SPECT imaging and radioguided surgery in prostate cancer
by: Leonardo Lima Fuscaldi, et al.
Published: (2023-10-01) -
Preparation and Clinical Translation Study of 99mTc-labeled Prostate-Specific Membrane Antigen Inhibitor HYNIC-P137
by: DUAN Xiaojiang;LIAO Xuhe;XIAO Di;ZHANG Zhuochen;ZHANG Junbo;FAN Yan;YANG Xing
Published: (2023-08-01) -
A Review on the Current State and Future Perspectives of [<sup>99m</sup>Tc]Tc-Housed PSMA-i in Prostate Cancer
by: Sara Brunello, et al.
Published: (2022-04-01)